close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

VivoPower PLC - Class A Ordinary Shares (NQ:VIVO)

2.420 -0.180 (-6.92%)
Delayed Quote Updated: 9:47 AM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about VivoPower PLC - Class A Ordinary Shares

< Previous 1 2 3 4 Next >
News headline image
Prediction: Apple Will Be the Worst "Magnificent Seven" Stock to Own Between Now and 2030 ↗
A trio of concerns are weighing on the company. 
Via The Motley Fool
Topics Economy Retirement Supply Chain
News headline image
Why Is VivoPower Stock Up 30% Today? ↗
VivoPower PLC (NASDAQ: VIVO) shares are trading sharply higher Wednesday afternoon as investors react to a pair of recent company moves aimed at reducing dilution and tightening the stock's publicly... 
Via Benzinga
News headline image
DoubleVerify To Join S&P SmallCap 600 On January 31 ↗
 
Via Benzinga
Meridian Bioscience's Return On Capital Employed Overview ↗
 
Via Benzinga
Cannabis Stock Gainers And Losers From December 12, 2022 ↗
 
Via Benzinga
News headline image
Meridian Bioscience To Be Acquired By SD Biosensor, SJL Partners - Read For How Much ↗
 
Via Benzinga
News headline image
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire ↗
This quartet of stocks has plenty of growth ahead and is already profitable. 
Via The Motley Fool
News headline image
Silk Road Medical Stock Scores Relative Strength Rating Upgrade ↗
Silk Road Medical sees its Relative Strength Rating reach the elite 90-plus level. 
Via Investor's Business Daily
News headline image
Penumbra Stock Hits 80-Plus Relative Strength Rating Benchmark ↗
Penumbra stock cleared a key 80-plus relative strength benchmark Monday, with a jump to 87 from 79 on Friday. 
Via Investor's Business Daily
News headline image
Looking Into Meridian Bioscience's Return On Capital Employed ↗
Meridian Bioscience (NASDAQ:VIVO) brought in sales totaling $67.77 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 125.52%, resulting in a loss of $7.34... 
Via Benzinga
News headline image
Meridian Bioscience: Q3 Earnings Insights ↗
  Meridian Bioscience (NASDAQ:VIVO) reported its Q3 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Preview: Meridian Bioscience's Earnings ↗
Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that Meridian... 
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2022 ↗
Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million. 
Via Benzinga
News headline image
Recap Of Friday's Biotech Catalysts - End of The Day Summary ↗
 
Via Benzinga
News headline image
Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating ↗
Silk Road Medical stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 69 to 90. 
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022 ↗
 
Via Benzinga
News headline image
MERIDIAN BIOSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Meridian Bioscience, Inc. - VIVO
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Dear AMC Stock Fans, Mark Your Calendars for Aug. 4 ↗
AMC Entertainment (AMC) stock is in the news today as investors in the theater company prepare for a potential catalyst coming next month! 
Via InvestorPlace
News headline image
Meridian Biosciences (VIVO) Stock Trending on $1.5 Billion Buyout Agreement ↗
VIVO stock is a hot topic on Wall Street today, not just because Meridian Biosciences released a fiscal update, but also due to takeover news. 
Via InvestorPlace
News headline image
VIVO Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Meridian Bioscience, Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
News headline image
Cannabis Stock Gainers And Losers From July 6, 2022 ↗
GAINERS: Tilray Brands (NASDAQ:TLRY) shares closed up 8.02% at $3.50 
Via Benzinga
News headline image
Marijuana Stock Movers For June 30, 2022 ↗
GAINERS: Marrone Bio Innovations (NASDAQ:MBII) shares closed up 6.42% at $1.16 
Via Benzinga
News headline image
EXCLUSIVE: Has Biotech Bottomed? NYSE Executive Floor Director Says Biogen And These 3 Stocks Look Poised To Outperform ↗
Markets continue to trend lower amid rising inflation and Fed uncertainty, but one New York Stock Exchange floor director says the bottom may be in for a couple of beaten-down sectors. 
Via Benzinga
News headline image
Cannabis Stock Movers For June 29, 2022 ↗
GAINERS: Cansortium (OTC:CNTMF) shares closed up 4.07% at $0.17 
Via Benzinga
News headline image
Cannabis Stock Movers For June 28, 2022 ↗
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 16.35% at $0.79 
Via Benzinga
News headline image
Cannabis Stock Gainers And Losers From June 27, 2022 ↗
GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 46.08% at $0.02 
Via Benzinga
News headline image
Cannabis Stock Gainers And Losers From June 17, 2022 ↗
GAINERS: Origin Agritech (NASDAQ:SEED) shares closed up 10.10% at $7.63 
Via Benzinga
News headline image
Cannabis Stock Movers For June 9, 2022 ↗
GAINERS: Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares closed up 35.09% at $1.29 LOSERS: 
Via Benzinga
News headline image
Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 8, 2022 ↗
GAINERS: Cansortium (OTC:CNTMF) shares closed up 12.00% at $0.22 
Via Benzinga
News headline image
Cannabis Stock Movers For June 6, 2022 ↗
GAINERS: Leviathan Natural Prods (OTC:LVCNF) shares closed up 17.12% at $0.87 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.